"Recently, reports emerged stating that PharmAGRI Capital Partners will be tapping into Tesla's humanoid robots for its operations. The firm claimed that it had executed a Letter of Intent with Tesla to deploy up to 10,000 Optimus Gen 3+ humanoid robots across its SuperPharm and CEA facilities. This should allow the company to automate its labor and ensure diversion control."
"News of PharmAGRI's Optimus claims quickly spread on social media, though some Tesla watchers argued that it seemed unlikely that the EV maker will commit two legions of Optimus robots to a rather unknown company this early. Some pointed out that Tesla typically commits to high-profile customers to test its early products, such as PepsiCo with the Tesla Semi. Photos from PharmAGRI's website depicting Tesla Optimus bots, as well as the rather basic look of the website itself, also brought more reservations to the company's claims."
PharmAGRI Capital Partners claimed a Letter of Intent with Tesla to deploy up to 10,000 Optimus Gen 3+ humanoid robots across SuperPharm and CEA facilities to automate labor and ensure diversion control. A company executive asserted that Tesla robotics would power facilities with DEA-licensed infrastructure to scale with precision and meet federal sourcing mandates. Observers raised doubts due to Tesla's tendency to test early products with high-profile customers and concerns about PharmAGRI's website presentation. Tesla publicly labeled the claim fake while Optimus continues in active development.
Read at TESLARATI
Unable to calculate read time
Collection
[
|
...
]